Skip to content

Clinical study on vascular immunity of hypertension (Grade 1, low or medium risk) of Yin deficiency Yang hyperactivity syndrome

Clinical study on vascular immunity of hypertension (Grade 1, low or medium risk) of Yin deficiency Yang hyperactivity syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072646
Enrollment
Unknown
Registered
2023-06-20
Start date
2023-06-20
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Sponsors

Affiliated Hospital of Shanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)18-65 years old (including boundary age), male or female. (2)The diagnosis of primary hypertension in Fuhe clinic is accurate, the grade of high blood pressure is grade 1 (SBP140~159mmHg and / or DBP90~99mmHg), and the risk stratification belongs to low and medium risk. (3)TCM syndrome differentiation is Yin deficiency and Yang hyperactivity syndrome. (4)Those who do not take antihypertensive drugs or take antihypertensive drugs regularly within one month. (5)The basic principle of freely given informed consent for all subjects.

Exclusion criteria

Exclusion criteria: (1) There are obvious abnormal liver and kidney function, ALT, AST or serum creatinine are more than 2 times higher than the upper limit of normal value. (2) People who are allergic or allergic to known ingredients of the experimental drug. (3) Women of childbearing age who are pregnant, breastfeeding, have pregnancy intention or have positive pregnancy test (urine HCG), and are unable to take effective contraceptive measures (including sterilization, intrauterine device, oral contraceptive or local law) during the study period. (4) Patients who have participated in clinical trials of other drugs or medical devices in the past 3 months. (5) Diagnosis of mental and neurological diseases and inability to express volunteers correctly. (6) Alcoholics and drug abusers and addicts.

Design outcomes

Primary

MeasureTime frame
24h arteria blood pressure monitoring;

Secondary

MeasureTime frame
Diastolic blood pressure dropped at 6 weekend;Diastolic and systolic blood pressure dropped at 6 weekend;Blood pressure compliance rate at 4 and 6 weekend ;TCM syndrome score;Three items of hypertension hormones;

Countries

China

Contacts

Public ContactZhigeng Hu

Affiliated Hospital of Shanxi University of Chinese Medicine

13835172121@126.com+86 138 3517 2121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026